Tuberculosis deserves an effort as “substantial” as the one mounted against swine flu “to develop a new vaccine,” David McMurray, a TB expert at Texas A&M University System Health Science Center, writes in a Houston Chronicle opinion piece. “Since April, … nearly one million men, women and children have died from TB, compared to 4,200 who have died from H1N1 flu globally. Why didn’t you see any headlines? Because 98 percent of the nearly two million people who die each year from TB live in the developing world, in places like Kenya … Yet TB continues to be a problem in [the U.S.] as well because in an age of globalization, germs cross borders without a passport,” McMurray writes.
New studies suggest that “[d]eveloping countries with limited access to advanced health-care facilities may be in for a rough ride with swine [H1N1] flu and even countries with high-tech ICUs may find themselves pushed to the limit as their hospitals struggle to save gravely ill H1N1 patients,” the Canadian Press reports. The studies, which compare outcomes among H1N1 patients admitted to intensive care units in Canada and Mexico,” show “the death rate in the latter was more than double that seen among Canadian patients. Just over 40 percent of critically ill Mexican patients succumbed to their illness by day 60, compared to 17.3 percent of Canadian patients by day 90.” The findings were reported online in the Journal of the American Medical Association (JAMA) on Monday.
As countries around the world roll out H1N1 (swine flu) virus vaccine campaigns, the Atlantic examines, “[W]hat if everything we think we know about fighting influenza is wrong?”
About 100 low- and middle-income countries could receive donated shipments of the H1N1 (swine flu) vaccine as early as November, Marie-Paule Kieny, of the WHO, told journalists Monday, Agence France-Presse reports. “Dozens of millions of doses are being lined up following offers from pharmaceutical companies,” including Sanofi-Aventis, GlaxoSmithKline and MedImmune, as well as a coalition of developed nations “that have pledged to release 10 percent of their vaccine purchases for poor nations,” the news service writes (10/12).
The WHO concluded a three-day meeting on H1N1 (swine flu) in Washington, D.C., on Friday, where health experts issued recommendations that patients with symptoms of H1N1 and pneumonia be treated quickly with antivirals, even before the results of H1N1 tests are complete, the San Francisco Chronicle blog, “ChronRX” reports.
The Washington Post examines H1N1 vaccine supplies across the U.S.: “With only a fraction of the tens of millions of doses of vaccine that authorities predicted would be available arriving in states, cities and towns, public health officials who spent months planning for a massive immunization program are instead scrambling to parcel out their limited supply of nasal sprays and shots,” the newspaper writes.
President Barack Obama declared the H1N1 (swine) flu outbreak a national emergency, the Wall Street Journal reports. “The declaration, which Mr. Obama signed Friday, authorizes the administration to waive or modify certain federal requirements involving Medicare, Medicaid and health-privacy rules to speed treatment,” the newspaper writes (McKay/Simpson/Whalen, 10/26).
CDC Says U.S. H1N1 Vaccine Supplies On The Rise; Senators Question Government’s Handling Of H1N1 Vaccination Program
Supplies of the H1N1 (swine flu) vaccine are steadily increasing in the U.S. and should soon be more widely accessible in the next two weeks, the CDC said on Tuesday, CQ HealthBeat reports. During a press briefing, CDC Director Thomas Frieden said that 22.4 million vaccine doses are now available for states to order (Norman, 10/27).
The New York Times examines how Saudi Arabia is preparing for the upcoming annual pilgrimage of some “2.5 million people from 160 countries” to Mecca, some who “will be bringing the swine flu.”
The U.S. will hold off on donating H1N1 (swine flu) vaccine stockpiles to developing countries until “at-risk Americans” receive the vaccine, HHS Secretary Kathleen Sebelius said Wednesday, Agence France-Presse reports. Last month, the U.S. pledged to donate H1N1 vaccine stockpiles to developing countries. However, manufacturing delays of the H1N1 vaccine have driven the supply to “about 10 million doses short of the 40 million doses they had expected to have by the end of this month,” the news service writes.